Therapy News and Research

RSS

Pharmacist Services Technical Advisory Coalition awarded grant from Community Pharmacy Foundation

The Pharmacist Services Technical Advisory Coalition (PSTAC), an alliance of seven national pharmacy organizations, has recently been awarded a grant from the Community Pharmacy Foundation to support an educational campaign on Current Procedural Terminology (CPT) codes used for Medication Therapy Management Services (MTMS) provided by pharmacists.

28 Aug 2007

New ESC guidelines on cardiac pacing and cardiac resynchronization therapy

The European Society of Cardiology has released new guidelines for Cardiac Pacing and Cardiac Resynchronization Therapy. These new guidelines cover two main areas: The permanent pacing in bradyarrhythmias, syncope and other specific conditions like hypertrophic obstructive cardiomyopathy and ventricular resynchronization as an adjunct therapy in patients with heart failure.

28 Aug 2007

Animal model for dengue research

A mosquito-borne disease often known as "break-bone fever" has found a new enemy in a unique type of mouse.

28 Aug 2007

Scientists identifiy successfully reprogrammed cells by looks alone

Some scientific results are hard to spot, especially in genetic research. Often scientists are unable to physically see if the gene they inserted into a cell has produced the desired trait.

28 Aug 2007

Nasal spray effective for most severe kind of headache

A nasal spray is safe and effective at rapidly treating cluster headaches, which are considered to be the most painful kind of headache with few treatment options, according to a study published in the August 28, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

28 Aug 2007

IDM Pharma receives not approvable letter for Mifamurtide for treatment of osteosarcoma

IDM Pharma, Inc. ( NASDAQ:IDMI ) announced today that it received a not approvable letter from the U.S. Food and Drug Administration (FDA) after completing the review of the new drug application (NDA) for the investigational drug mifamurtide (L-MTP-PE), formerly known as Junovan, for the treatment of non-metastatic osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.

28 Aug 2007

New understanding of factor YY1 in gene expression

The Conaway Lab - led by Joan Conaway, Ph.D., and Ron Conaway, Ph.D., Investigators - has published findings that shed light on the role of the much-studied transcription factor YY1 in gene expression.

28 Aug 2007

Novel heart repair therapy could be in the pipeline

The success of a new and experimental stem cell treatment used in animals could lead to a novel heart repair therapy for heart attack patients.

27 Aug 2007

Avastin approved in Europe for advanced lung cancer

Avastin (bevacizumab), Roche's innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.

26 Aug 2007

Oglufanide disodium in new hepatitis C trial

Physicians at Southern Health have started a phase IIa clinical trial designed to test the efficacy of a new strategy for defeating hepatitis C viral infection, one of the toughest infectious diseases in the modern world.

26 Aug 2007

New findings on vocal cord dysfunction

Vocal cord dysfunction (VCD) is the sudden, abnormal narrowing closure of the vocal cords during inhalation causing obstruction of the airflow, and is characterized by a noise that can mimic the sound of wheezing. A VCD attack can easily be mistaken for an asthma attack though it does not respond to asthma medications.

24 Aug 2007

Nanoparticle drug delivery system for brain tumor therapy shows promise

A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists.

24 Aug 2007

Nuclear nanocapsules to target tiny tumors

Rice University chemists have found a way to package some of nature's most powerful radioactive particles inside DNA-sized tubes of pure carbon -- a method they hope to use to target tiny tumors and even lone leukemia cells.

24 Aug 2007

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

24 Aug 2007

Potential new therapy for treatment of neurodegenerative diseases

Researchers have provided new information about how communication among neurons may be prevented from deteriorating in conditions such as Alzheimer's disease (AD).

24 Aug 2007

Breakthrough for Huntington's disease

A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds.

24 Aug 2007

New diabetes mellitus clinical practice guidelines

The American Association of Clinical Endocrinologists (AACE) has announced the release of its medical guidelines for the diagnosis and management of diabetes mellitus.

24 Aug 2007

Rapamycin study is first stage in development of new treatment

Rapamycin isn't your ordinary potential anti-cancer drug…It had a long and somewhat exotic history before undergoing preclinical (laboratory-based) studies at St. Jude as part of a national Pediatric Preclinical Testing Program (PPTP) investigation of its anticancer activity.

23 Aug 2007

Cancer stem cell scientists get $1.7 million to develop new leukemia drugs

"Modern cancer treatments fail to get to the root of the cancer - the stem cells - which is why many cancers recur despite aggressive treatment."

23 Aug 2007

Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy

Using metal nanoshells designed to both absorb and scatter near-infrared light, a team of investigators at Rice University has shown that such nanoparticles can both image and treat tumors in animals. Their experiments revealed complete tumor destruction in more than 80 percent of animals treated with these nanoshells.

22 Aug 2007